AI assistant
SILICON LABORATORIES INC. — Director's Dealing 2011
May 16, 2011
31118_dirs_2011-05-16_0f567a6e-4765-4dd3-9b45-52f8d0a52718.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: SILICON LABORATORIES INC (SLAB)
CIK: 0001038074
Period of Report: 2011-05-12
Reporting Person: Tuttle George Tyson (COO)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $0.0001 par value | 60347 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $32.11 | 2017-02-15 | Common Stock, $0.0001 par value (13000) | Direct | |
| Non-Qualified Stock Option (right to buy) | $31.96 | 2018-02-15 | Common Stock, $0.0001 par value (11511) | Direct |
Footnotes
F1: Includes 43,795 restricted stock units (RSUs) that will entitle Reporting Person to receive one share of common stock per RSU. 13,911 RSUs will vest on February 15, 2012 and will be settled pursuant to the terms of the Issuer's 2000 Stock Incentive Plan. 7,169 RSUs will vest on February 15, 2012, 14,339 RSUs will vest on February 15, 2013, and 8,376 RSUs will vest on February 15, 2014 and will be settled pursuant to the terms of the Issuer's 2009 Stock Incentive Plan.
F2: Originally granted 30,000 option shares. Option vests and becomes exercisable with respect to (i) twenty percent (20%) of the total granted option shares on the date exercisable and (ii) the balance of the total granted option shares in a series of forty-eight (48) successive monthly installments over the forty-eight (48) month period measured from the date exercisable.
F3: Originally granted 21,250 option shares. Option vests and becomes exercisable with respect to (i) twenty-five percent (25%) of the total granted option shares on the date exercisable and (ii) the balance of the total granted option shares in a series of thirty-six (36) successive monthly installments over the thirty-six (36) month period measured from the date exercisable.